Type 2 diabetes detection based on serum sample Raman spectroscopy.

Area of Science:

• Biomedical Spectroscopy
• Analytical Chemistry
• Medical Diagnostics

Background:

• Type 2 diabetes mellitus (T2DM) diagnosis relies on established methods, but non-invasive, supportive techniques are needed.
• Biochemical alterations in blood serum are associated with T2DM, presenting potential biomarkers.
• Raman spectroscopy offers label-free molecular fingerprinting capabilities for biological samples.

Purpose of the Study:

• To investigate the efficacy of Raman spectroscopy for detecting type 2 diabetes using blood serum.
• To identify specific spectral differences between healthy individuals and T2DM patients.
• To develop a classification method for T2DM detection based on Raman spectral data.

Main Methods:

• Serum samples were collected from 15 type 2 diabetes patients and 20 healthy volunteers.
• Raman spectra were acquired and analyzed, focusing on characteristic peak differences.
• Principal Component Analysis (PCA) and Linear Discriminant Analysis (LDA) were employed for classification.

Main Results:

• Significant spectral differences were observed between healthy and T2DM serum samples, particularly at specific Raman shifts (e.g., 661, 1404, 714, 605, 545 cm^-1, and amide III region).
• A distinct region (897-955 cm^-1) showed increased peak intensity in T2DM samples.
• PCA and LDA achieved high sensitivity and specificity in classifying samples, with the first principal component highlighting key spectral differences.

Conclusions:

• Serum Raman spectroscopy is a promising non-invasive technique for type 2 diabetes detection.
• The method can serve as a valuable adjunct to existing diagnostic tools.
• Raman spectroscopy has the potential to improve diagnostic accuracy and reduce false-positive rates in T2DM screening.